Star Combo Pharma Ltd (S66) — Cash Flow Reinvestment Rate
Star Combo Pharma Ltd (S66) has a Cash Flow Reinvestment Rate of 0.51x as of December 2025, reinvesting AU$295.53K (capex AU$295.53K ) from operating cash flow of AU$575.23K. See Star Combo Pharma Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Star Combo Pharma Ltd Cash Flow Reinvestment Rate (2016–2025)
Historical reinvestment intensity for Star Combo Pharma Ltd across 6 annual periods. For the full cash flow conversion analysis, see Star Combo Pharma Ltd (S66) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Star Combo Pharma Ltd (2016–2025)
Year-by-year capital reinvestment analysis for Star Combo Pharma Ltd. See S66 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (AUD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.03x | AU$393.72K | AU$11.94 Million | AU$393.72K | ▼ -99.0% |
| 2023 | 3.17x | AU$5.96 Million | AU$1.88 Million | AU$2.73 Million | ▼ -97.6% |
| 2022 | 130.24x | AU$11.35 Million | AU$87.11K | AU$7.29 Million | ▲ +192.1% |
| 2021 | 44.59x | AU$14.78 Million | AU$331.53K | AU$7.26 Million | ▲ +15817.9% |
| 2017 | 0.28x | AU$261.13K | AU$932.20K | AU$261.13K | ▼ -68.3% |
| 2016 | 0.88x | AU$1.15 Million | AU$1.30 Million | AU$1.15 Million | — |